Felipe Prosper - Universidad de Navarra

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 799 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure S2 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S4 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S9 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

crossref（2024）

Cited0Views0Bibtex

Natural Hydrogels Support Kidney Organoid Generation and Promote in Vitro Angiogenesis

Elena Garreta,Daniel Moya-Rull,Andres Marco, Gaia Amato,Asier Ullate-Agote,Carolina Tarantino,Maria Gallo,David Esporrin-Ubieto, Alberto Centeno,Amaia Vilas-Zornoza,Rafael Mestre, Maria Kalil,Izar Gorronogoitia,Ane Miren Zaldua,Samuel Sanchez, Laura Izquierdo Reyes,Maria Eugenia Fernandez-Santos,Felipe Prosper,Nuria Montserrat

ADVANCED MATERIALSno. 34 (2024)

Cited0Views0WOSBibtex

Supplementary Table S8 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S6 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

crossref（2024）

Cited0Views0Bibtex

A Bioreactor for Celullarised Membrane Culture and Delivery under Sterile Conditions

Ainitze Gereka,Uzuri Urtaza, Pablo Larreategi,Felipe Prosper,Enrique Jose Andreu,Ane Miren Zaldua

BIOENGINEERING-BASELno. 8 (2024)

Cited0Views0WOSBibtex

Supplementary Figure S5 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S4 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S5 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn